Precipio, Inc. (PRPO): Price and Financial Metrics

Precipio, Inc. (PRPO): $1.83

0.00 (0.00%)

POWR Rating

Component Grades













Add PRPO to Watchlist
Sign Up

Industry: Biotech


of 493

in industry

PRPO Stock Summary

  • With a market capitalization of $33,181,675, Precipio Inc has a greater market value than just 6.97% of US stocks.
  • As for revenue growth, note that PRPO's revenue has grown 94.82% over the past 12 months; that beats the revenue growth of 94.47% of US companies in our set.
  • Precipio Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -28.14%, greater than the shareholder yield of merely 9.06% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to Precipio Inc, a group of peers worth examining would be MGPI, PKE, IPDN, GHM, and JVA.
  • Visit PRPO's SEC page to see the company's official filings. To visit the company's web site, go to

PRPO Stock Price Chart Interactive Chart >

Price chart for PRPO

PRPO Price/Volume Stats

Current price $1.83 52-week high $8.00
Prev. close $1.83 52-week low $0.55
Day low $1.72 Volume 215,782
Day high $1.88 Avg. volume 732,985
50-day MA $2.54 Dividend yield N/A
200-day MA $2.36 Market Cap 33.18M

Precipio, Inc. (PRPO) Company Bio

Precipio, Inc. operates as a biotechnology company. The Company offers medicines for oncology, cardiology, neurology, and inherited diseases. Precipio also provides specialized clinical and research services to biopharmaceutical companies developing targeted therapies. Precipio serves customers in the United States.

PRPO Latest News Stream

Event/Time News Detail
Loading, please wait...

PRPO Latest Social Stream

Loading social stream, please wait...

View Full PRPO Social Stream

Latest PRPO News From Around the Web

Below are the latest news stories about Precipio Inc that investors may wish to consider to help them evaluate PRPO as an investment opportunity.

Precipio launches up to $20M ATM financing arrangement

Precipio ([[PRPO]] -1.7%) launched a new At-The-Market financing arrangement wherein it can sell shares up to an aggregate of $20M.The company foresees that this will be its primary financing method going forward.This arrangement will be used in an ongoing manner to finance Precipio's operations and provide the resources the company needs to...

Seeking Alpha | April 5, 2021

Precipio, Inc. (PRPO) CEO Ilan Danieli on Q4 2020 Results - Earnings Call Transcript

Precipio, Inc. (PRPO) Q4 2020 Earnings Conference Call Mar 31, 2021, 05:00 PM ET Company Participants Ilan Danieli - CEO Carl Iberger - CFO Conference Call Participants Presentation Operator Welcome to the Precipio Q4 2020 and Yearend Shareholder Update Call. All participants will be in a listen-only mode. [Operator Instructions]...

SA Transcripts on Seeking Alpha | April 1, 2021

Precipio, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 31, 2021 / Precipio, Inc. (NASDAQ:PRPO) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 31, 2021 at 5:00 PM Eastern Time.

Yahoo | March 31, 2021

Precipio Announces 95% Annual Growth YoY and 180% Quarterly Growth YoY

HemeScreen projected to rapidly become a material revenue contributor in 2021 FY-2020FY-2019Increase (%)Increase ($)Revenues$6.1M$3.1M↑ 95%↑ $3.0MGross profit$1.2M$0.3M↑ 425%↑ $0.9M Q4-2020Q3-2020 Increase (%)Increase ($)Revenues$1.9M$1.6M↑ 19%↑ $0.3MGross profit$0.5M$0.4M↑ 27%↑ $0.1M NEW HAVEN, Conn., March 30, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics Company Precipio, Inc. (NASDAQ: PRPO), announced its audited results for 2020. The Company posted revenues of $6.1 million, an increase of $3.0 million from 2019, representing a 95% year-over-year increase. Additionally, Q4-2020 revenues of $1.9 million represent a 180% increase from revenues of $0.7 million in Q4-2019 and, if continued, would represent an annualized revenue run rate of approximately $8.0 million entering 2021. The ...

Yahoo | March 30, 2021

Precipio Announces Q4-2020 and year-end Shareholder Update Call

Conference Call to be held on Wednesday, March 31st, 2021 at 5:00 PM ESTNEW HAVEN, Conn., March 18, 2021 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q4-2020 and year end corporate update call on Wednesday, March 31st at 5:00 PM ET. The call will include updates on all of the company’s current core businesses. The conference call may be accessed by calling 844-695-5519 (international callers dial 1-412-902-6760). All callers should ask for the Precipio Inc. conference call. Participants may also pre-register for the conference call to and will receive a calendar invite and a direct dial-in number, bypassing the operator. Listeners interested in submitting questions in advance s...

Yahoo | March 18, 2021

Read More 'PRPO' Stories Here

PRPO Price Returns

1-mo -29.34%
3-mo -25.31%
6-mo -15.28%
1-year 188.51%
3-year -72.27%
5-year -99.44%
YTD -11.59%
2020 0.98%
2019 -8.89%
2018 -87.50%
2017 -85.71%
2016 -73.83%

Continue Researching PRPO

Want to see what other sources are saying about Precipio Inc's financials and stock price? Try the links below:

Precipio Inc (PRPO) Stock Price | Nasdaq
Precipio Inc (PRPO) Stock Quote, History and News - Yahoo Finance
Precipio Inc (PRPO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 2.058 seconds.